•
Dec 31, 2024

IDEX Q4 2024 Earnings Report

IDEX reported record sales and increased EPS, driven by acquisitions and organic growth in specific segments.

Key Takeaways

IDEX Corporation reported a strong fourth quarter with record sales of $863 million, a 9% increase overall and 3% organically. The company's diluted EPS rose by 13% to $1.62, and adjusted diluted EPS increased by 11% to $2.04. Growth was driven by acquisitions and positive returns in fire safety and diversified products, while the health & science technologies segment showed strong organic orders growth.

Record sales of $863 million, up 9% overall and 3% organically.

Diluted EPS of $1.62, up 13%; adjusted diluted EPS of $2.04, up 11%.

Fire & Safety/Diversified Products teams achieved another quarter of record sales and solid organic growth.

Health & Science Technologies segment experienced strong organic orders growth.

Total Revenue
$863M
Previous year: $789M
+9.4%
EPS
$2.04
Previous year: $1.83
+11.5%
Gross Profit
$367M
Previous year: $337M
+9.0%
Cash and Equivalents
$621M
Previous year: $534M
+16.2%
Free Cash Flow
$157M
Previous year: $179M
-12.4%
Total Assets
$6.75B
Previous year: $5.87B
+15.0%

IDEX

IDEX

IDEX Revenue by Segment

Forward Guidance

IDEX projects full year organic sales to increase 1% to 3% over the prior year and GAAP diluted EPS of $6.56 to $6.96 (adjusted diluted EPS of $8.10 to $8.45). For the first quarter of 2025, organic sales are projected to decrease 3% to 4% from the prior year period, with GAAP diluted EPS of $1.18 to $1.24 (adjusted diluted EPS of $1.60 to $1.65).

Positive Outlook

  • Full year organic sales are projected to increase 1% to 3% over the prior year
  • Full year GAAP diluted EPS of $6.56 to $6.96 (adjusted diluted EPS of $8.10 to $8.45)
  • Strong price capture realized across all segments.
  • Targeted growth initiatives and industrial projects contributed to sales growth.
  • Continued recovery in fire original equipment manufacturer markets.

Challenges Ahead

  • First quarter 2025 organic sales are projected to decrease 3% to 4% from the prior year period
  • First quarter GAAP diluted EPS of $1.18 to $1.24 (adjusted diluted EPS of $1.60 to $1.65)
  • Cyclical softness in the life sciences, automotive, and semiconductor markets.
  • Unfavorable mix and higher employee-related costs impacted Adjusted EBITDA margin in Fire & Safety/Diversified Products.
  • Geopolitical and economic uncertainty heading into 2025.

Revenue & Expenses

Visualization of income flow from segment revenue to net income